Update: 18.07.2023
Last week: 27 week 2023 (03.07.2023 - 09.07.2023)
Last full month: June 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 60 372 | -4.2% | 2.8% | -0.1 | 14 450 236 | -4.7% | 3.0% | -0.2 | -0.8% |
| MoM | 287 038 | -8.7% | 2.8% | 0.1 | 69 325 574 | -11.4% | 3.1% | 0 | -13.4% |
| YTD | 2 368 472 | -61.8% | 2.7% | -3.2 | 612 082 152 | -50.0% | 3.2% | -2.4 | -16.5% |
| MAT | 6 017 442 | -59.5% | 3.2% | -3.5 | 1 407 372 870 | -48.9% | 3.5% | -2.7 | -15.1% |
| DEXALGIN | |||||||||
| WoW | 19 516 | 2.3% | 0.4% | 0 | 9 938 589 | 2.5% | 1.2% | 0 | 2.0% |
| MoM | 81 267 | 15.4% | 0.4% | 0.1 | 40 761 006 | 14.2% | 1.2% | 0.1 | 0.3% |
| YTD | 468 221 | -57.2% | 0.4% | -0.4 | 243 708 471 | -46.1% | 1.1% | -1 | -7.3% |
| MAT | 960 705 | -54.2% | 0.4% | -0.4 | 477 960 099 | -42.9% | 1.2% | -0.9 | -8.2% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 61 161 | 4.7% | 39.6% | -0.5 | 35 275 711 | 4.6% | 46.1% | -0.3 | 6.0% |
| MoM | 247 607 | 5.4% | 39.8% | -0.1 | 144 530 399 | 3.9% | 46.7% | -0.5 | 5.6% |
| YTD | 1 499 413 | -46.6% | 39.9% | -18.9 | 917 166 762 | -35.2% | 48.3% | -15.9 | -21.2% |
| MAT | 2 977 536 | -45.9% | 42.3% | -19.4 | 1 710 863 340 | -36.3% | 49.7% | -17.4 | -21.0% |
| ESPUMISAN BABY | |||||||||
| WoW | 23 387 | 12.3% | 32.8% | 1.3 | 16 913 521 | 12.3% | 47.0% | 1.4 | 7.9% |
| MoM | 92 893 | 5.3% | 32.7% | 1.5 | 68 479 934 | 5.5% | 47.4% | 1.1 | 0.5% |
| YTD | 565 514 | -32.3% | 30.7% | -9.1 | 427 498 778 | -16.8% | 46.5% | -6.4 | -12.3% |
| MAT | 1 156 126 | -29.1% | 32.4% | -8 | 819 123 622 | -16.9% | 47.0% | -6.9 | -11.6% |
| FASTUM | |||||||||
| WoW | 17 063 | 10.6% | 1.0% | 0.1 | 10 313 708 | 12.1% | 2.4% | 0.2 | 1.7% |
| MoM | 65 519 | 2.6% | 0.8% | 0 | 39 279 575 | 1.9% | 2.1% | 0 | -0.8% |
| YTD | 402 394 | -37.7% | 0.9% | -0.4 | 244 045 281 | -25.4% | 2.2% | -0.5 | -5.4% |
| MAT | 797 124 | -38.5% | 0.9% | -0.5 | 463 286 911 | -26.4% | 2.2% | -0.6 | -4.7% |
| IODOMARIN | |||||||||
| WoW | 74 955 | 11.0% | 24.0% | 0.1 | 13 484 812 | 11.1% | 10.2% | 0.1 | 10.5% |
| MoM | 281 695 | 1.3% | 22.9% | 0.1 | 50 556 856 | 0.3% | 9.4% | 0.1 | 0.8% |
| YTD | 1 836 224 | 14.8% | 22.8% | 4.3 | 336 611 881 | 4.1% | 9.3% | 0.8 | -6.7% |
| MAT | 3 529 839 | 6.4% | 22.9% | 2.3 | 653 174 018 | 1.4% | 9.6% | 0.2 | -4.5% |
| LIOTON | |||||||||
| WoW | 23 034 | 5.6% | 2.2% | 0 | 28 929 314 | 6.8% | 4.6% | 0 | 4.7% |
| MoM | 99 565 | 13.5% | 2.1% | 0.2 | 122 413 385 | 9.7% | 4.7% | 0.2 | 2.4% |
| YTD | 502 928 | -37.0% | 2.0% | -0.8 | 630 889 915 | -21.9% | 4.5% | -0.5 | -12.7% |
| MAT | 955 734 | -40.2% | 2.1% | -1 | 1 130 413 366 | -24.5% | 4.3% | -1.1 | -12.4% |
| MEZYM | |||||||||
| WoW | 216 862 | 5.0% | 17.9% | 0.2 | 35 489 709 | 5.4% | 12.6% | 0 | 3.7% |
| MoM | 882 207 | 1.1% | 17.8% | 0.3 | 142 318 636 | 3.3% | 12.4% | 0.2 | -0.5% |
| YTD | 5 732 950 | -50.6% | 18.4% | -11.1 | 906 554 504 | -49.0% | 12.6% | -8.6 | -20.7% |
| MAT | 11 471 687 | -50.6% | 19.1% | -11.8 | 1 774 444 956 | -47.7% | 13.2% | -9.2 | -20.0% |
| MIG 400 | |||||||||
| WoW | 98 951 | -7.4% | 2.0% | -0.2 | 13 723 028 | -7.2% | 1.6% | -0.2 | 2.0% |
| MoM | 499 064 | -5.4% | 2.5% | -0.2 | 69 190 969 | -1.7% | 2.0% | -0.1 | 0.3% |
| YTD | 3 152 220 | -35.4% | 2.4% | -1.1 | 402 842 485 | -29.6% | 1.9% | -0.8 | -7.3% |
| MAT | 6 670 975 | -35.6% | 2.6% | -1.1 | 825 165 179 | -30.3% | 2.0% | -0.9 | -8.2% |
| PROSTAMOL | |||||||||
| WoW | 22 200 | 17.3% | 14.4% | 1.8 | 35 967 402 | 27.7% | 16.7% | 3.1 | 2.5% |
| MoM | 83 911 | -0.4% | 13.1% | -0.1 | 125 068 636 | 1.5% | 14.2% | 0.1 | 0.1% |
| YTD | 552 201 | -43.7% | 13.1% | -7.7 | 824 699 749 | -40.1% | 14.4% | -7.7 | -10.3% |
| MAT | 1 118 462 | -45.2% | 14.0% | -8.8 | 1 611 942 016 | -41.0% | 15.0% | -9.1 | -10.6% |
| RESPERO MYRTOL | |||||||||
| WoW | 14 197 | 8.2% | 8.0% | 0.7 | 7 689 373 | 8.7% | 8.4% | 0.7 | -1.5% |
| MoM | 66 022 | -11.4% | 7.4% | 0.8 | 34 761 396 | -11.5% | 7.4% | 0.8 | -20.7% |
| YTD | 543 005 | -24.9% | 7.0% | -1.8 | 299 258 516 | -11.1% | 7.6% | -1 | -5.5% |
| MAT | 1 121 853 | -9.1% | 7.4% | -0.4 | 586 259 858 | 3.2% | 8.0% | 0.2 | -3.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 2 368 472 | -61.8% | 2.7% | -3.2 | 612 082 152 | -50.0% | 3.2% | -2.4 | -16.5% |
| DEXALGIN | 468 221 | -57.2% | 0.4% | -0.4 | 243 708 471 | -46.1% | 1.1% | -1 | -7.3% |
| ESPUMISAN (ADULTS) | 1 499 413 | -46.6% | 39.9% | -18.9 | 917 166 762 | -35.2% | 48.3% | -15.9 | -21.2% |
| ESPUMISAN BABY | 565 514 | -32.3% | 30.7% | -9.1 | 427 498 778 | -16.8% | 46.5% | -6.4 | -12.3% |
| FASTUM | 402 394 | -37.7% | 0.9% | -0.4 | 244 045 281 | -25.4% | 2.2% | -0.5 | -5.4% |
| IODOMARIN | 1 836 224 | 14.8% | 22.8% | 4.3 | 336 611 881 | 4.1% | 9.3% | 0.8 | -6.7% |
| LIOTON | 502 928 | -37.0% | 2.0% | -0.8 | 630 889 915 | -21.9% | 4.5% | -0.5 | -12.7% |
| MEZYM | 5 732 950 | -50.6% | 18.4% | -11.1 | 906 554 504 | -49.0% | 12.6% | -8.6 | -20.7% |
| MIG | 3 152 220 | -35.4% | 2.4% | -1.1 | 402 842 485 | -29.6% | 1.9% | -0.8 | -7.3% |
| PROSTAMOL | 552 201 | -43.7% | 13.1% | -7.7 | 824 699 749 | -40.1% | 14.4% | -7.7 | -10.3% |
| RESPERO MYRTOL | 543 005 | -24.9% | 7.0% | -1.8 | 299 258 516 | -11.1% | 7.6% | -1 | -5.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 017 442 | -59.5% | 3.2% | -3.5 | 1 407 372 870 | -48.9% | 3.5% | -2.7 | -15.1% |
| DEXALGIN | 960 705 | -54.2% | 0.4% | -0.4 | 477 960 099 | -42.9% | 1.2% | -0.9 | -8.2% |
| ESPUMISAN (ADULTS) | 2 977 536 | -45.9% | 42.3% | -19.4 | 1 710 863 340 | -36.3% | 49.7% | -17.4 | -21.0% |
| ESPUMISAN BABY | 1 156 126 | -29.1% | 32.4% | -8 | 819 123 622 | -16.9% | 47.0% | -6.9 | -11.6% |
| FASTUM | 797 124 | -38.5% | 0.9% | -0.5 | 463 286 911 | -26.4% | 2.2% | -0.6 | -4.7% |
| IODOMARIN | 3 529 839 | 6.4% | 22.9% | 2.3 | 653 174 018 | 1.4% | 9.6% | 0.2 | -4.5% |
| LIOTON | 955 734 | -40.2% | 2.1% | -1 | 1 130 413 366 | -24.5% | 4.3% | -1.1 | -12.4% |
| MEZYM | 11 471 687 | -50.6% | 19.1% | -11.8 | 1 774 444 956 | -47.7% | 13.2% | -9.2 | -20.0% |
| MIG | 6 670 975 | -35.6% | 2.6% | -1.1 | 825 165 179 | -30.3% | 2.0% | -0.9 | -8.2% |
| PROSTAMOL | 1 118 462 | -45.2% | 14.0% | -8.8 | 1 611 942 016 | -41.0% | 15.0% | -9.1 | -10.6% |
| RESPERO MYRTOL | 1 121 853 | -9.1% | 7.4% | -0.4 | 586 259 858 | 3.2% | 8.0% | 0.2 | -3.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 60 372 | -4.2% | 2.8% | -0.1 | 14 450 236 | -4.7% | 3.0% | -0.2 | -0.8% |
| DEXALGIN | 19 516 | 2.3% | 0.4% | 0 | 9 938 589 | 2.5% | 1.2% | 0 | 2.0% |
| ESPUMISAN (ADULTS) | 61 161 | 4.7% | 39.6% | -0.5 | 35 275 711 | 4.6% | 46.1% | -0.3 | 6.0% |
| ESPUMISAN BABY | 23 387 | 12.3% | 32.8% | 1.3 | 16 913 521 | 12.3% | 47.0% | 1.4 | 7.9% |
| FASTUM | 17 063 | 10.6% | 1.0% | 0.1 | 10 313 708 | 12.1% | 2.4% | 0.2 | 1.7% |
| IODOMARIN | 74 955 | 11.0% | 24.0% | 0.1 | 13 484 812 | 11.1% | 10.2% | 0.1 | 10.5% |
| LIOTON | 23 034 | 5.6% | 2.2% | 0 | 28 929 314 | 6.8% | 4.6% | 0 | 4.7% |
| MEZYM | 216 862 | 5.0% | 17.9% | 0.2 | 35 489 709 | 5.4% | 12.6% | 0 | 3.7% |
| MIG | 98 951 | -7.4% | 2.0% | -0.2 | 13 723 028 | -7.2% | 1.6% | -0.2 | 2.0% |
| PROSTAMOL | 22 200 | 17.3% | 14.4% | 1.8 | 35 967 402 | 27.7% | 16.7% | 3.1 | 2.5% |
| RESPERO MYRTOL | 14 197 | 8.2% | 8.0% | 0.7 | 7 689 373 | 8.7% | 8.4% | 0.7 | -1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 287 038 | -8.7% | 2.8% | 0.1 | 69 325 574 | -11.4% | 3.1% | 0 | -13.4% |
| DEXALGIN | 81 267 | 15.4% | 0.4% | 0.1 | 40 761 006 | 14.2% | 1.2% | 0.1 | 0.3% |
| ESPUMISAN (ADULTS) | 247 607 | 5.4% | 39.8% | -0.1 | 144 530 399 | 3.9% | 46.7% | -0.5 | 5.6% |
| ESPUMISAN BABY | 92 893 | 5.3% | 32.7% | 1.5 | 68 479 934 | 5.5% | 47.4% | 1.1 | 0.5% |
| FASTUM | 65 519 | 2.6% | 0.8% | 0 | 39 279 575 | 1.9% | 2.1% | 0 | -0.8% |
| IODOMARIN | 281 695 | 1.3% | 22.9% | 0.1 | 50 556 856 | 0.3% | 9.4% | 0.1 | 0.8% |
| LIOTON | 99 565 | 13.5% | 2.1% | 0.2 | 122 413 385 | 9.7% | 4.7% | 0.2 | 2.4% |
| MEZYM | 882 207 | 1.1% | 17.8% | 0.3 | 142 318 636 | 3.3% | 12.4% | 0.2 | -0.5% |
| MIG | 499 064 | -5.4% | 2.5% | -0.2 | 69 190 969 | -1.7% | 2.0% | -0.1 | 0.3% |
| PROSTAMOL | 83 911 | -0.4% | 13.1% | -0.1 | 125 068 636 | 1.5% | 14.2% | 0.1 | 0.1% |
| RESPERO MYRTOL | 66 022 | -11.4% | 7.4% | 0.8 | 34 761 396 | -11.5% | 7.4% | 0.8 | -20.7% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs